Sentiment Trading

Inhibikase Therapeutics, a clinical-stage pharmaceutical company, is making progress in developing treatments for neurodegenerative diseases through its innovative kinase inhibitor therapeutics.

Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company making significant strides in developing innovative treatments for neurodegenerative diseases through its small-molecule kinase inhibitor therapeutics.